Assessment by optical coherence tomography of stent struts across side branch-comparison of bare-metal stents and drug-eluting stents

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 107-112

  Liu, Yong ^a   Imanishi, Toshio ^a   Kubo, Takashi ^a   Tanaka, Atsushi ^a   Kitabata, Hironori ^a   Tanimoto, Takashi ^a   Ino, Yasushi ^a   Ikejima, Hideyuki ^a   Tsujioka, Hiroto ^a   Komukai, Kenichi ^a   Ishibashi, Kohei ^a   Kashiwagi, Manabu ^a   Ozaki, Yuichi ^a   Hirata, Kumiko ^a   Mizukoshi, Masato ^a   Akasaka, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bifurcation; Neointima; Optical coherence tomography; Stents

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON OCCLUSION; BARE METAL STENT; BLOOD VESSEL DIAMETER; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; RISK FACTOR; STENT THROMBOSIS; STRUCTURE ANALYSIS; SURGICAL ANATOMY; THROMBOGENESIS; THROMBOSIS PREVENTION;

EID: 78651248741     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0574     Document Type: Article

References (22)

1. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 2004; 364: 583-591.
2. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
3. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434.
4. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
5. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003; 108: 1701-1706.
6. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Sukmawan R, et al. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005; 46: 1133-1136.
7. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005; 111: 1551-1555.
8. Dzavik V, Kharbanda R, Ivanov J, Ing DJ, Bui S, Mackie K, et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: Importance of the bifurcation angle. Am Heart J 2006; 152: 762-769.
9. Xie Y, Takano M, Murakami D, Yamamoto M, Okamatsu K, Inami S, et al. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation. Am J Cardiol 2008; 102: 27-31.
10. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: Comparison with bare-metal stents. Circulation 2007; 116: 910-916.
11. Chen BX, Ma FY, Luo W, Ruan JH, Xie WL, Zhao XZ, et al. Neo-intimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography. Heart 2008; 94: 566-570.
12. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
13. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293: 2126-2130.
14. Kim JS, Kim JS, Kim TH, Fan C, Lee JM, Kim W, et al. Comparison of neointimal coverage of sirolimus-eluting stents and pacli-taxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 2010; 74: 320-326.
15. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 1988; 112: 1018-1031.
16. Goodall AH. Role of shear stress and turbulence on platelets in blood conduits and on endothelial cells in arterial conduits. In: Sigwart U, editor. Endoluminal stenting. London: WB Saunders, 1996; 65-78.
17. Xu YX, Collins MW. Fluid dynamics in stents. In: Sigwart U, editor. Endoluminal stenting. London: WB Saunders, 1996; 52-59.
18. Welt FG, Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 2002; 22: 1769-1776.
19. Katoh H, Shite J, Shinke T, Matsumoto D, Tanino Y, Ogasawara D, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009; 73: 1033-1037.
20. Kalsho G, Kassab GS. Bifurcation asymmetry of the porcine coronary vasculature and its implications on coronary fow heterogeneity. Am J Physiol Heart Circ Physiol 2004; 287: 2493-2500.
21. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009; 119: 987-995.
22. Takano M, Yamamoto M, Inami S, Murakami D, Seimiya K, Ohba T, et al. Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: Do uncovered struts persist? J Am Coll Cardiol 2008; 51: 968-973.